China Art Financial Holdings Limited

HKEX:1572.HK

0.095 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 53.4356.3077.38519.95321.97820.91830.7925.94663.678100.291128.212128.987161.637114.862111.69266.68478.59829.28226.89414.42514.42514.42514.4259.9679.9679.9679.967
Cost of Revenue 35.6412.0120.1991.4524.9630.5263.0040.0483.492.0930.6883.0781.3960.3530.5782.8791.0410.331000000000
Gross Profit 17.7944.2957.18618.50117.01520.39227.78625.89860.18898.198127.524125.909160.241114.509111.11463.80577.55728.95126.89414.42514.42514.42514.4259.9679.9679.9679.967
Gross Profit Ratio 0.3330.6810.9730.9270.7740.9750.9020.9980.9450.9790.9950.9760.9910.9970.9950.9570.9870.989111111111
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 3.8863.8862.4072.4074.4473.9924.9634.6449.30711.23226.78320.66117.33515.83612.0023.8543.2731.7183.3641.3331.3331.3331.3331.2631.2631.2631.263
Selling & Marketing Expenses 1.16500.010000-0.122-0.265-0.3237.4737.9713.9844.7261.9291.2061.2270.906-1.839-0.492-0.492-0.492-0.492-0.682-0.682-0.682-0.682
SG&A 0.7473.8860.8012.4074.4473.9924.9634.5229.04210.90934.25628.63131.31920.56213.9315.064.52.6241.5250.8410.8410.8410.8410.5810.5810.5810.581
Other Expenses 000000000000000000000000000
Operating Expenses 7.594.0977.0092.7392.5042.694.8936.38511.067.84638.48128.1731.52623.34823.22318.06915.2414.2851.5250.8410.8410.8410.8410.5810.5810.5810.581
Operating Income 16.4724.4336.34518.99812.56816.422.82321.47251.14687.28994.151102.551127.88393.09396.33556.73970.70124.66618.3819.519.519.519.516.1256.1256.1256.125
Operating Income Ratio 0.3080.7030.8590.9520.5720.7840.7410.8280.8030.870.7340.7950.7910.810.8630.8510.90.8420.6830.6590.6590.6590.6590.6140.6140.6140.614
Total Other Income Expenses Net -5.6271.215-4.370.973.3312.75110.9932.4054.7724.197-3.1431.3322.242-1.932-8.474-11.003-6.30303.8852.632.632.632.631.9391.9391.9391.939
Income Before Tax 10.8455.6481.97519.96815.89919.15133.81623.87755.91891.48691.008103.883130.12591.16187.86145.73664.39824.66622.26612.1412.1412.1412.148.0648.0648.0648.064
Income Before Tax Ratio 0.2030.8960.2671.0010.7230.9161.0980.920.8780.9120.710.8050.8050.7940.7870.6860.8190.8420.8280.8420.8420.8420.8420.8090.8090.8090.809
Income Tax Expense 3.2612.2131.4295.9184.3185.3696.8426.9514.91524.96228.89628.70833.7526.925.8614.30519.8146.8566.6683.0353.0353.0353.0352.0162.0162.0162.016
Net Income 7.5843.4350.54614.0511.58113.78226.97416.92741.00366.52462.11275.17596.37564.26162.00127.91535.59511.25915.5999.1059.1059.1059.1056.0486.0486.0486.048
Net Income Ratio 0.1420.5450.0740.7040.5270.6590.8760.6520.6440.6630.4840.5830.5960.5590.5550.4190.4530.3850.580.6310.6310.6310.6310.6070.6070.6070.607
EPS 0.0050.00200.0080.0070.0080.0160.010.0240.0410.0390.0470.060.040.0470.0270.0450.0290.0260.0240.0240.0240.0240.0160.0160.0160.016
EPS Diluted 0.0050.00200.0080.0070.0080.0160.010.0240.0410.0390.0470.060.040.0470.0270.0450.0290.0260.0240.0240.0240.0240.0160.0160.0160.016
EBITDA 16.5084.5536.38319.12912.66916.522.82422.10651.6387.60594.836103.262128.63493.56396.73157.13771.11125.07918.5879.7149.7149.7149.7146.2526.2526.2526.252
EBITDA Ratio 0.3090.7220.8640.9590.5760.7890.7410.8520.8110.8740.740.8010.7960.8150.8660.8570.9050.8560.6910.6730.6730.6730.6730.6270.6270.6270.627